Results 311 to 320 of about 527,379 (343)
Some of the next articles are maybe not open access.
Interleukin-12, interleukin-23, and psoriasis: Current prospects
Journal of the American Academy of Dermatology, 2007The clinical phenotype of psoriasis results from infiltration of T cells in the skin and elaboration of inflammatory cytokines. Interleukin (IL)-12 and, more recently, IL-23 have been implicated in the pathogenesis of psoriatic lesions. New therapies, including a monoclonal antibody against a subunit shared by IL-12 and IL-23, have been developed to ...
Dorothea C, Torti, Steven R, Feldman
openaire +2 more sources
Pathophysiology of Interleukin-23 in Experimental Autoimmune Encephalomyelitis
Drug News & Perspectives, 2006Interleukin-23 (IL-23) is a heterodimeric cytokine that is composed of a p40 subunit, shared with the closely related cytokine IL-12, and a smaller IL-23p19 subunit. It belongs to a family of heterodimeric cytokines that also includes IL-12 and IL-27.
Tarik, Touil +4 more
openaire +2 more sources
The critical role of interleukin-23 in spondyloarthropathy
Molecular Immunology, 2014The spondyloarthropathies represent highly enigmatic conditions and although their clinical features, anatomical distribution of disease and genetic predisposing factors have been known for some time, a unified concept of the basic pathobiology underlying these illnesses has remained undefined.
Jonathan P, Sherlock +2 more
openaire +2 more sources
Sarcopenia and interleukin-23 in colorectal cancer survival
Clinical Nutrition, 2022Shupeng, Gao, Yan, Li
openaire +2 more sources
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Cancer Cell, 2022Yared Hailemichael +2 more
exaly
Spondyloarthropathy: interleukin 23 and disease modification
The Lancet, 2015Jonathan P, Sherlock +3 more
openaire +2 more sources
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
New England Journal of Medicine, 2021Anthony C Gordon +2 more
exaly